Phase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid Tumors

NCT01985555 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hutchison Medipharma Limited